Patients with lupus benefit from COVID-19 vaccine booster
People with systemic lupus erythematosus (SLE) who received a “booster” dose of SARS-CoV-2 vaccine after full vaccination are roughly half as likely to have a subsequent “breakthrough” COVID-19 infection, a new study shows.